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CXCLl2 is involved in diabetic retinopathy, and decreased secretion in diabetes 
contributes to defective vascular progenitor cell mobilisation, leading to 
macrovascular complications. Adipocytes could be an important source of CXCLl2 
and other chemokines. The SCF A butyrate stimulates, while other histone deacetylase 
(HDAC) inhibitors (valproate and trichostatin) inhibit, adipogenesis. 
3T3-Ll cells were grown to confluence and studied as preadipocytes or differentiated 
adipocytes. Butyrate increased CXCLl2 mRNA 5-fold (p < 0.001) and protein 
secretion 2-fold (p < 0.001) in preadipocytes. CXCLl2 was expressed in adipocytes, 
but butyrate had modest effects on gene expression and did not affect protein 
secretion. 
CXCLl2 mRNA and protein were not increased in preadipocytes by octanoate or by 
valproate or trichostatin. SCFAs increased CXCLl2 secretion in preadipocytes, with 
potency propionate > butyrate > acetate consistent with action through the GPR 41. 
Pertussis toxin (5 ng/ml), which inhibits receptor-G protein interaction, was without 
effect alone but abolished the stimulatory effect of SCFA on CXCLl2 expression. 
SCFA did not affect VEGF mRNA, but decreased VEGF secretion in preadipocytes. 
In adipocytes, butyrate increased VEGF mRNA and protein (41% and 22%, p < 0.01 
and P < 0.05, respectively) whereas HDAC inhibitors decreased VEGF secretion. 
Hypoxia increased VEGF mRNA (p < 0.001), but decreased CXCLl2 (p < 0.001). 
MCP-1 was predominantly expressed in preadipocytes, and up-regulated by SCFA (p 
< 0.001). mRNA for CXCR4, the receptor for CXCLl2 was not detected in 
preadipocytes or adipocytes, but was present in monocytic cells. GPR41 mRNA was 
detected in preadipocytes and adipocytes. GPR43, the other known SCFA receptor, 
was only present in adipocytes. 
CXCLl2 may mediate interaction of adipocytes with immune and vascular cells, 
Regulation by SCFA and hypoxia differs to that of VEGF. Increased preadipocyte 
differentiation in obesity may contribute to decreased CXCLl2 and this may be partly 
reversed by functional foods which increase SCF A. 
